CLINICAL TRIALS AND OBSERVATIONS Risk of thyroid cancer, brain cancer, and non-Hodgkin lymphoma after adult leukemia: a nationwide study

نویسندگان

  • Sune F. Nielsen
  • Stig E. Bojesen
  • Henrik S. Birgens
  • Børge G. Nordestgaard
چکیده

Patients with childhood leukemia surviving into adulthood have elevated risk of developing thyroid cancer, brain cancer, and non-Hodgkin lymphoma (NHL); these risks cannot automatically be extrapolated to patients surviving adult leukemia. We tested whether survivors of adult leukemia are at increased risk of developing thyroid cancer, brain cancer, and NHL. We included the entire adult Danish population (14 years of age or older), in a 28-year follow-up period from 1980 through 2007, composed of 6 542 639 persons; during this period, 18 834 developed adult leukemia, 4561 developed thyroid cancer, 13 362 developed brain cancer, and 15 967 developed NHL. In nested studies using Cox regression models on individual participant data, we found that, after adult leukemia, the multivariate adjusted hazard ratios were 4.9 (95% confidence interval [CI], 2.8-8.5) for thyroid cancer, 1.9 (95% CI, 1.2-3.1) for brain cancer, and 3.3 (95% CI, 2.5-4.4) for NHL. Corresponding hazard ratios after childhood leukemia were 10.4 (95% CI, 0.4-223) for thyroid cancer, 7.2 (95% CI, 2.0-26) for brain cancer, and 6.5 (95% CI, 0.4-110) for NHL. Patients with adult leukemia have excess risk of thyroid cancer, brain cancer, and NHL, similar to patients with childhood leukemia. (Blood. 2011;118(15):4062-4069)

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

CLINICAL TRIALS AND OBSERVATIONS Inhibition of Syk with fostamatinib disodium has significant clinical activity in non-Hodgkin lymphoma and chronic lymphocytic leukemia

1James P. Wilmot Cancer Center, University of Rochester, NY; 2Stanford University, CA; 3Cleveland Clinic, OH; 4Mayo Clinic, Rochester, MN; 5University of Nebraska, Omaha; 6Dana-Farber Cancer Institute, Boston, MA; 7University of California at Los Angeles; 8Emory University, Atlanta, GA; 9Cornell University, New York, NY; 10Indiana University, Indianapolis; 11Rush University, Chicago, IL; and 12...

متن کامل

CLINICAL TRIALS AND OBSERVATIONS Results of a randomized international study of high-risk central nervous system B non-Hodgkin lymphoma and B acute lymphoblastic leukemia in children and adolescents

Results of a randomized international study of high-risk central nervous system B non-Hodgkin lymphoma and B acute lymphoblastic leukemia in children and adolescents Mitchell S. Cairo,1 Mary Gerrard,2 Richard Sposto,3 Anne Auperin,4 C. Ross Pinkerton,5 Jean Michon,6 Claire Weston,7 Sherrie L. Perkins,8 Martine Raphael,9 Keith McCarthy,10 and Catherine Patte,4 on behalf of the FAB LMB96 Internat...

متن کامل

CLINICAL OBSERVATIONS, INTERVENTIONS, AND THERAPEUTIC TRIALS Second cancers and late toxicities after treatment of aggressive non-Hodgkin lymphoma with the ACVBP regimen: a GELA cohort study on 2837 patients

The survival of patients with aggressive non-Hodgkin lymphoma (NHL) is increasing, but the incidence of secondary cancer and late toxicity is poorly defined for those treated with cyclophosphamidehydroxydaunomycin/doxorubicin-Oncovin-prednisone (CHOP)–like chemotherapy. From February 1984 to January 1998, 2837 patients with aggressive NHL received the control-arm chemotherapy adriamycin-cycloph...

متن کامل

ژن‌های سرطان/بیضه، معرفی ژن TSGA10: مقاله مروری

Cancer/Testis antigens (CTAs) as a group of tumor antigens are the novel subjects for developing cancer vaccine and immunotherapy approaches. They aberrantly express in tumors with highest normal expression in testis, and limited or no expression in normal tissues. There are important similarities between the processes of germ-cell and cancer cell development Spermatogenesis begins at puberty w...

متن کامل

CLINICAL TRIALS AND OBSERVATIONS Clinical efficacy of zanolimumab (HuMax-CD4): two phase 2 studies in refractory cutaneous T-cell lymphoma

1Multidisciplinary Cutaneous Lymphoma Program, Stanford Comprehensive Cancer Center, CA; 2M.D. Anderson Cancer Center, Houston, TX; 3Aarhus University Hospital, Denmark; 4Bispebjerg Hospital, Copenhagen, Denmark; 5Karolinska Hospital, Stockholm, Sweden; 6St Thomas’ Hospital, London, United Kingdom; 7Manchester University, Christie Hospital, United Kingdom; 8Department of Dermatology, University...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

عنوان ژورنال:

دوره   شماره 

صفحات  -

تاریخ انتشار 2011